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 Summary
   In 2003-2006 1068 excision biopsies (USG-, MGR- guided anchor biopsies) were performed in OCCD. 
In 182 patients (17%), USG-guided biopsies were performed.
  The youngest patient was 22 years old, the oldest 84, the mean age in the group was 53 years. The 
group consisted of 77 premenopausal patients (42%) and 105 (58%) postmenopausal ones. The family 
histories of 32 patients (17.5%) were positive. 169 (93%) had undergone mammography, including 
115, for whom it was the first examination of that type in their life. The lesions were located most 
frequently in the upper lateral quadrant of the mammary gland (89 patients – 49%). In 5 patients, 
the lesions were of multifocal character. In 29 (16%), MGR revealed microcalcifications.
  All the patients underwent USG of the breasts. In 122 (68.5%), the lesions visualized by USG were 
hypoechogenic. Only in 4 (2%), the lesions revealed by USG were suspicious of cancer. The mean 
lesion size was 13 mm (range 4–60 mm). All the patients underwent surgical treatment. Partial 
resection of breast tissue localized by means of a USG-guided needle was performed. The results of 
histopathological investigations of the surgical material were as follows: 43 patients (23.5%) were 
diagnosed with malignant tumors, 
  139 (76.5%) – with benign ones. Among the benign tumors, adenofibroma was predominant 
(72 patients – 52%), among the malignant ones – carcinoma infiltrans (35 patients – 81.4%). 
After ultimate histopathology results were obtained, 17 patients underwent BCT, 17 – Madden 
mastectomy, 2 – simple mastectomy, and 3 patients developed tumors in the other breast which 
was operated on by Madden mastectomy.
  The following conclusions, based on the analysis of own material, were drawn:
  1.  USG-guided excision biopsy on case of ambiguous findings in breast USG is an effective method, 
both in diagnostics and in therapy.
  2.  In the OCCD material, 23.5% of patients with ambiguous USG findings were diagnosed histo-
pathologically with malignant tumors, which confirms the necessity to perform excision biopsies.
  3.  Only good cooperation between the radiologist and the surgeon guarantees the success of this method.
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Background
Availability of breast imaging techniques (ultrasonography, 
mammography) has led to an increased rate of detection of 
subclinical lesions [1, 2]. In most cases, such lesions require 
verification by microscopy. Fine needle aspiration biopsy 
has been the „golden standard” so far [3, 4]. At present, the 
indications for this type of biopsy have been limited signi-
ficantly.
Large core needle biopsy, USG-guided mammotome biopsy, 
stereotaxic mammotome biopsy are becoming  increasingly 
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popular [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]. Excision biopsy 
(USG-guided anchor biopsy) is an established diagnostic, 
and in some cases also therapeutic, method. This method 
involves excision of a breast tissue fragment previous-
ly localized by a radiologist with a localization needle, 
together with a margin of normal tissue [16] and sending 
the material for histopathological investigation. The pro-
cedure is usually performed under local anesthesia. The 
method is employed in case of ambiguous breast USG 
 findings.
Materials and methods
In 2003–2006 1068 excision biopsies (USG-, MGR- 
guided anchor biopsies) were performed in OCCD. In 
182 patients (17%), USG-guided anchor biopsies were 
performed.
The youngest patient was 22 years old, the oldest 84, 
the mean age in the group was 53 years. The group con-
sisted of 77 premenopausal patients (42%) and 105 (58%) 
postmenopausal ones. The family histories of 32 patients 
(17.5%) were positive. 169 (93%) had undergone mammo-
graphy, including 115, for whom it was the first exami-
nation of that type in their life. The lesions were located 
most frequently in the upper lateral quadrant of the mam-
mary gland (89 patients – 49%). In 5 patients, the lesions 
were of multifocal character. In 29 (16%), MGR revealed 
microcalcifications. All the patients underwent USG of 
the breasts.
Table 1 presents character of the lesions in USG.
Table 1. Character of the lesions in USG.
Character of the lesion in USG Number of patients %
HYPOECHOGENIC 122 68.5
HYPERECHOGENIC 1 0.5
ISOECHOGENIC 1 0.5
MIXED ECHOGENICITY 21 11.5
SIMPLE CYST 1 0.5
HIGH DENSITY CYST 3 1.5
CYST WITH INTERNAL 
HYPERPLASIA 5 2.5
MULTIPLE CYSTS 2 1.0
DUCTAL DILATATION 6 3.0
DUCTAL HYPERPLASIA 1 0.5
FA 15 8.0
CA 4 2.0
In 122 patients, accounting for 68.5% of the analyzed 
group, the lesions found in USG were hypoechogenic. 
Only in 4 cases (2%) the lesions shown by USG were suspi-
cious of cancer. The mean lesion size was 13 mm (range 
4–60 mm). 
Results
All the patients underwent surgical treatment. Partial resec-
tion of breast tissue localized by means of a USG-guided 
needle was performed. The surgical material was sent for 
histopathological investigation. The results of histopatholo-
gical investigations of the surgical material were as follows: 
43 patients (23.5%) were diagnosed with malignant tumors, 
139 (76.5%) – with benign ones.
Table 2 presents histological findings in benign tumors.
Table 2. Histological findings in benign tumors.
TYPES Number of patients %
FA 72 52.0
CYST 1 0.7
RADIAL SCAR 3 2.1
PAPILLOMA 10 7.2
FIBROCYST 15 10.8
MASTOPATHY 26 18.7
Non-ADH 7 6.4
ADH 2 1.4
Among the benign lesions, adenofibroma was predominant 
– 72 patients (52%).
Table 3 presents histological findings in malignant tumors.
Table 3. Histological findings in malignant tumors.
TYPES Number of patients %
CDIS 6 14.0
CLIS 2 4.6
Ca infiltrans:
– LOBULARE
– TUBULARE
– DUCTALE
35
7
2
26
81.4
20.0
6.0
74.0
Amonth the malignant tumors, carcinoma infiltrans was 
predominant – 35 patients (81.4%).
Table 4 presents the correlation of USG findings with 43 
histopathologically malignant lesions
After ultimate histopathology results were obtained, 17 
patients underwent BCT, 17 – Madden mastectomy, 2 – sim-
ple mastectomy, and 146 – tumor resection.
The results obtained in the group of 17 out of 43 patients 
with histologically malignant tumors (39.5%), who under-
went Madden operations, were analyzed thoroughly. It 
was found that the reason for radical surgery in 7 patients 
was the lack of margins in histopathological investigation, 
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in 3 the lesion was localized centrally, in 2 it was larger 
than 3.5 cm in size, and 5 gave no consent for conservative 
 surgery.
Discussion
Forty three patients, accounting for 23.5% of the analy-
zed group, were diagnosed histopathologically with malig-
nant tumors. This justifies the claim that USG-guided 
excision biopsy method is effective in case of ambiguous 
USG findings. Good cooperation between the radiologist 
and the surgeon is indispensable in this procedure. This 
is another example illustrating the fact that the “golden 
years” of fine needle aspiration biopsy are coming to 
an end [3, 4].
Conclusions
The following conclusions, based on the analysis of own 
material, were drawn:
1.  USG-guided excision biopsy on case of ambiguous find-
ings in breast USG is an effective method, both in diag-
nostics and in therapy.
2.  In the OCCD material, 23.5% of patients with ambiguous 
USG findings were diagnosed histopathologically with 
malignant tumors, which confirms the necessity to per-
form excision biopsies.
3.  Only good cooperation between the radiologist and the 
surgeon guarantees the success of this method.
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Table 4.  Correlation of USG findings with 43 histopathologically 
malignant lesions.
Character of the 
lesion in USG
Number 
of patients %
Ca+ 43 
pts
HYPOECHOGENIC 122 68.5 35
HYPERECHOGENIC 1 0.5 1
ISOECHOGENIC 1 0.5 -
MIXED ECHOGENICITY 21 11.5 3
SIMPLE CYST 1 0.5 -
HIGH DENSITY CYST 3 1.5 -
CYST WITH INTERNAL 
HYPERPLASIA 5 2.5 -
MULTIPLE CYSTS 2 1.0 -
DUCTAL DILATATION 6 3.0 1
DUCTAL HYPERPLASIA 1 0.5 -
FA 15 8.0 -
CA 4 2.0 3
